https://www.cityam.com/british-biotech-firm-immunocore-opts-for-new-york-float/
British biotech firm Immunocore opts for New York float
Jan 18, 2021 - Cancer biotech firm Immunocore is looking to list on the Nasdaq rather than London as it aims to raise up to $100m.
for new yorkbritish biotechfirmimmunocorefloat